Abbott Laboratories & GenBioPro

Abbott Laboratories: Abbott Laboratories, the maker of mifepristone, received temporary relief from Samuel Alito's order, allowing continued mail access to the drug. The company appealed to the United States — Supreme Court of the United States to set aside the appellate court's order and expressed concern about the 'immediate confusion and upheaval' caused by the 5th Circuit's decision.

GenBioPro: GenBioPro, a manufacturer of a generic version of mifepristone, also received temporary relief from Samuel Alito's order. The company appealed to the United States — Supreme Court of the United States, stating that the 5th Circuit's decision 'unleashed regulatory chaos' and threatened access to mifepristone nationwide.

Abbott Laboratories: Abbott Laboratories, the maker of mifepristone, filed an emergency appeal to the United States — Supreme Court of the United States, which led to the temporary restoration of access to the drug.

GenBioPro: GenBioPro, a manufacturer of a generic version of mifepristone, also filed an emergency appeal, contributing to the United States — Supreme Court of the United States's decision to restore access.

Abbott Laboratories: Abbott Laboratories, a manufacturer of Mifepristone, is a defendant in the lawsuit and has requested a hold on the appeals court's order to seek relief from the United States — Supreme Court of the United States.

GenBioPro: GenBioPro, a generic Mifepristone manufacturer, stated that the court's decision ignores the United States — Food and Drug Administration's science and decades of safe use of the drug.